Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
Scott Kaatz(Hurley Medical Center), Jack Ansell(New York University), Stephan Moll(University of North Carolina at Chapel Hill), Alex C. Spyropolous(University of Rochester Medical Center), Thomas L. Ortel(Duke University), Anthony K.C. Chan(McMaster Children's Hospital), Peter A. Kouides(Mary M. Gooley Hemophilia Center), Mark Crowther(McMaster University), David García(University of Washington Medical Center), Elizabeth M. Van Cott(Massachusetts General Hospital), Jim Douketis(McMaster University), Allison James(Duke University)
Cited by 366
Related Papers
Prevention of VTE in Nonorthopedic Surgical Patients
|CHEST Journal|2012|2.1k
Prevention of VTE in Orthopedic Surgery Patients
|CHEST Journal|2012|1.9k
Management of Sickle Cell Disease
|JAMA|2014|1.6k